Staff Login
Japanese
| English
Contact Us
List
Search
Browse
Registration
Statistics
Search
Home
List
Reference
Patent
Reference - List
«
»
6 Hits
Search Condition : Filter (MeSH = Sorafenib / pharmacology)
Species
Resource
RRC ID
Title
Journal
Published
Link
Human and Animal Cells
HuH-7(RCB1366)
72959
Targeting DNA repair to enhance the efficacy of sorafenib in hepatocellular carcinoma.
J Cell Biochem
2022-10-1
Pubmed
Full text
Human and Animal Cells
HHUA(RCB0658)
71661
Sorafenib targets and inhibits the oncogenic properties of endometrial cancer stem cells via the RAF/ERK pathway.
Stem Cell Res Ther
2022-6-3
Pubmed
Full text
Human and Animal Cells
HuH-7(RCB1366)
68920
Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes-Associated Protein 1 Activation and Transient Expansion of Stem-Like Cancer Cells.
Hepatol Commun
2022-5-1
Pubmed
Full text
Human and Animal Cells
Hepa 1-6(RCB1638)
67501
The anti-angiogenic agent lenvatinib induces tumor vessel normalization and enhances radiosensitivity in hepatocellular tumors.
Med Oncol
2021-4-21
Pubmed
Full text
Human and Animal Cells
MIA Paca2(RCB2094)
,
HL-60(RCB3683)
66163
Establishment of live-cell-based coupled assay system for identification of compounds to modulate metabolic activities of cells.
Cell Rep
2021-7-6
Pubmed
Full text
Human and Animal Cells
HuH-7
58642
Upregulation of SNX5 predicts poor prognosis and promotes hepatocellular carcinoma progression by modulating the EGFR-ERK1/2 signaling pathway.
Oncogene
2020-3-1
Pubmed
Full text